Conduits based on the combination of hyaluronic acid and silk fibroin: Characterization, in vitro studies and in vivo biocompatibility

[EN] We address the production of structures intended as conduits made from natural biopolymers, capable of promoting the regeneration of axonal tracts. We combine hyaluronic acid (HA) and silk fibroin (SF) with the aim of improving mechanical and biological properties of HA. The results show that SF can be efficiently incorporated into the production process, obtaining conduits with tubular structure with a matrix of HA-SF blend. HA-SF has better mechanical properties than sole HA, which is a very soft hydrogel, facilitating manipulation. Culture of rat Schwann cells shows that cell adhesion and proliferation are higher than in pure HA, maybe due to the binding motifs contributed by the SF protein. This increased proliferation accelerates the formation of a tight cell layer, which covers the inner channel surface of the HA-SF tubes. Biocompatibility of the scaffolds was studied in immunocompetent mice. Both HA and HA-SF scaffolds were accepted by the host with no residual immune response at 8 weeks. New collagen extracellular matrix and new blood vessels were visible and they were present earlier when SF was present. The results show that incorporation of SF enhances the mechanical properties of the materials and results in promising biocompatible conduits for tubulization strategies.The authors acknowledge financing from the Spanish Ministry of Economy and Competitiveness through grants RTI2018-095872-B-C22/ERDF, DPI2015-72863-EXP, MAT2016-79832-R, MAT2016-76847-R and Community of Madrid through grant Neurocentro-B2017/BMD-3760. FGR acknowledges scholarship FPU16/01833 of the Spanish Ministry of Education, Culture and Sports. We thank the Electron Microscopy Service at the UPV, where the FESEM images were obtainedGisbert-Roca, F.; Lozano Picazo, P.; Pérez-Rigueiro, J.; Guinea Tortuero, GV.; Monleón Pradas, M.; Martínez-Ramos, C. (2020). Conduits based on the combination of hyaluronic acid and silk fibroin: Characterization, in vitro studies and in vivo biocompatibility. International Journal of Biological Macromolecules. 148:378-390. https://doi.org/10.1016/j.ijbiomac.2020.01.149S378390148Fawcett, J. W., & Asher, R. . (1999). The glial scar and central nervous system repair. Brain Research Bulletin, 49(6), 377-391. doi:10.1016/s0361-9230(99)00072-6Koeppen, A. H. (2004). Wallerian degeneration: history and clinical significance. Journal of the Neurological Sciences, 220(1-2), 115-117. doi:10.1016/j.jns.2004.03.008Hall, S. (2005). The response to injury in the peripheral nervous system. The Journal of Bone and Joint Surgery. British volume, 87-B(10), 1309-1319. doi:10.1302/0301-620x.87b10.16700Dubový, P., Klusáková, I., & Hradilová Svíženská, I. (2014). Inflammatory Profiling of Schwann Cells in Contact with Growing Axons Distal to Nerve Injury. BioMed Research International, 2014, 1-7. doi:10.1155/2014/691041Houschyar, K. S., Momeni, A., Pyles, M. N., Cha, J. Y., Maan, Z. N., Duscher, D., … Schoonhoven, J. van. (2016). The Role of Current Techniques and Concepts in Peripheral Nerve Repair. Plastic Surgery International, 2016, 1-8. doi:10.1155/2016/4175293Tian, L., Prabhakaran, M. P., & Ramakrishna, S. (2015). Strategies for regeneration of components of nervous system: scaffolds, cells and biomolecules. Regenerative Biomaterials, 2(1), 31-45. doi:10.1093/rb/rbu017Kehoe, S., Zhang, X. F., & Boyd, D. (2012). FDA approved guidance conduits and wraps for peripheral nerve injury: A review of materials and efficacy. Injury, 43(5), 553-572. doi:10.1016/j.injury.2010.12.030Collins, M. N., & Birkinshaw, C. (2013). Hyaluronic acid based scaffolds for tissue engineering—A review. Carbohydrate Polymers, 92(2), 1262-1279. doi:10.1016/j.carbpol.2012.10.028Cowman, M. K., & Matsuoka, S. (2005). Experimental approaches to hyaluronan structure. Carbohydrate Research, 340(5), 791-809. doi:10.1016/j.carres.2005.01.022Liang, Y., Walczak, P., & Bulte, J. W. M. (2013). The survival of engrafted neural stem cells within hyaluronic acid hydrogels. Biomaterials, 34(22), 5521-5529. doi:10.1016/j.biomaterials.2013.03.095Wang, T.-W., & Spector, M. (2009). Development of hyaluronic acid-based scaffolds for brain tissue engineering. Acta Biomaterialia, 5(7), 2371-2384. doi:10.1016/j.actbio.2009.03.033Ma, J., Tian, W.-M., Hou, S.-P., Xu, Q.-Y., Spector, M., & Cui, F.-Z. (2007). An experimental test of stroke recovery by implanting a hyaluronic acid hydrogel carrying a Nogo receptor antibody in a rat model. Biomedical Materials, 2(4), 233-240. doi:10.1088/1748-6041/2/4/005Tian, W. M., Hou, S. P., Ma, J., Zhang, C. L., Xu, Q. Y., Lee, I. S., … Cui, F. Z. (2005). Hyaluronic Acid–Poly-D-Lysine-Based Three-Dimensional Hydrogel for Traumatic Brain Injury. Tissue Engineering, 11(3-4), 513-525. doi:10.1089/ten.2005.11.513Vilariño-Feltrer, G., Martínez-Ramos, C., Monleón-de-la-Fuente, A., Vallés-Lluch, A., Moratal, D., Barcia Albacar, J. A., & Monleón Pradas, M. (2016). Schwann-cell cylinders grown inside hyaluronic-acid tubular scaffolds with gradient porosity. Acta Biomaterialia, 30, 199-211. doi:10.1016/j.actbio.2015.10.040Ortuño-Lizarán, I., Vilariño-Feltrer, G., Martínez-Ramos, C., Pradas, M. M., & Vallés-Lluch, A. (2016). Influence of synthesis parameters on hyaluronic acid hydrogels intended as nerve conduits. Biofabrication, 8(4), 045011. doi:10.1088/1758-5090/8/4/045011Vepari, C., & Kaplan, D. L. (2007). Silk as a biomaterial. Progress in Polymer Science, 32(8-9), 991-1007. doi:10.1016/j.progpolymsci.2007.05.013Murphy, A. R., & Kaplan, D. L. (2009). Biomedical applications of chemically-modified silk fibroin. Journal of Materials Chemistry, 19(36), 6443. doi:10.1039/b905802hSofia, S., McCarthy, M. B., Gronowicz, G., & Kaplan, D. L. (2000). Functionalized silk-based biomaterials for bone formation. Journal of Biomedical Materials Research, 54(1), 139-148. doi:10.1002/1097-4636(200101)54:13.0.co;2-7Altman, G. H., Diaz, F., Jakuba, C., Calabro, T., Horan, R. L., Chen, J., … Kaplan, D. L. (2003). Silk-based biomaterials. Biomaterials, 24(3), 401-416. doi:10.1016/s0142-9612(02)00353-8Horan, R. L., Antle, K., Collette, A. L., Wang, Y., Huang, J., Moreau, J. E., … Altman, G. H. (2005). In vitro degradation of silk fibroin. Biomaterials, 26(17), 3385-3393. doi:10.1016/j.biomaterials.2004.09.020Chi, N.-H., Yang, M.-C., Chung, T.-W., Chou, N.-K., & Wang, S.-S. (2013). Cardiac repair using chitosan-hyaluronan/silk fibroin patches in a rat heart model with myocardial infarction. Carbohydrate Polymers, 92(1), 591-597. doi:10.1016/j.carbpol.2012.09.012Chi, N.-H., Yang, M.-C., Chung, T.-W., Chen, J.-Y., Chou, N.-K., & Wang, S.-S. (2012). Cardiac repair achieved by bone marrow mesenchymal stem cells/silk fibroin/hyaluronic acid patches in a rat of myocardial infarction model. Biomaterials, 33(22), 5541-5551. doi:10.1016/j.biomaterials.2012.04.030Yang, M.-C., Chi, N.-H., Chou, N.-K., Huang, Y.-Y., Chung, T.-W., Chang, Y.-L., … Wang, S.-S. (2010). The influence of rat mesenchymal stem cell CD44 surface markers on cell growth, fibronectin expression, and cardiomyogenic differentiation on silk fibroin – Hyaluronic acid cardiac patches. Biomaterials, 31(5), 854-862. doi:10.1016/j.biomaterials.2009.09.096Zhou, J., Zhang, B., Liu, X., Shi, L., Zhu, J., Wei, D., … He, D. (2016). Facile method to prepare silk fibroin/hyaluronic acid films for vascular endothelial growth factor release. Carbohydrate Polymers, 143, 301-309. doi:10.1016/j.carbpol.2016.01.023Yan, S., Li, M., Zhang, Q., & Wang, J. (2013). Blend films based on silk fibroin/hyaluronic acid. Fibers and Polymers, 14(2), 188-194. doi:10.1007/s12221-013-0188-2Foss, C., Merzari, E., Migliaresi, C., & Motta, A. (2012). Silk Fibroin/Hyaluronic Acid 3D Matrices for Cartilage Tissue Engineering. Biomacromolecules, 14(1), 38-47. doi:10.1021/bm301174xJaipaew, J., Wangkulangkul, P., Meesane, J., Raungrut, P., & Puttawibul, P. (2016). Mimicked cartilage scaffolds of silk fibroin/hyaluronic acid with stem cells for osteoarthritis surgery: Morphological, mechanical, and physical clues. Materials Science and Engineering: C, 64, 173-182. doi:10.1016/j.msec.2016.03.063Fan, Z., Zhang, F., Liu, T., & Zuo, B. Q. (2014). Effect of hyaluronan molecular weight on structure and biocompatibility of silk fibroin/hyaluronan scaffolds. International Journal of Biological Macromolecules, 65, 516-523. doi:10.1016/j.ijbiomac.2014.01.058Chung, T.-W., & Chang, Y.-L. (2010). Silk fibroin/chitosan–hyaluronic acid versus silk fibroin scaffolds for tissue engineering: promoting cell proliferations in vitro. Journal of Materials Science: Materials in Medicine, 21(4), 1343-1351. doi:10.1007/s10856-009-3876-0Garcia-Fuentes, M., Meinel, A. J., Hilbe, M., Meinel, L., & Merkle, H. P. (2009). Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering. Biomaterials, 30(28), 5068-5076. doi:10.1016/j.biomaterials.2009.06.008Raia, N. R., Partlow, B. P., McGill, M., Kimmerling, E. P., Ghezzi, C. E., & Kaplan, D. L. (2017). Enzymatically crosslinked silk-hyaluronic acid hydrogels. Biomaterials, 131, 58-67. doi:10.1016/j.biomaterials.2017.03.046Yan, S., Zhang, Q., Wang, J., Liu, Y., Lu, S., Li, M., & Kaplan, D. L. (2013). Silk fibroin/chondroitin sulfate/hyaluronic acid ternary scaffolds for dermal tissue reconstruction. Acta Biomaterialia, 9(6), 6771-6782. doi:10.1016/j.actbio.2013.02.016Garcia-Fuentes, M., Giger, E., Meinel, L., & Merkle, H. P. (2008). The effect of hyaluronic acid on silk fibroin conformation. Biomaterials, 29(6), 633-642. doi:10.1016/j.biomaterials.2007.10.024Hu, X., Lu, Q., Sun, L., Cebe, P., Wang, X., Zhang, X., & Kaplan, D. L. (2010). Biomaterials from Ultrasonication-Induced Silk Fibroin−Hyaluronic Acid Hydrogels. Biomacromolecules, 11(11), 3178-3188. doi:10.1021/bm1010504Ren, Y.-J., Zhou, Z.-Y., Liu, B.-F., Xu, Q.-Y., & Cui, F.-Z. (2009). Preparation and characterization of fibroin/hyaluronic acid composite scaffold. International Journal of Biological Macromolecules, 44(4), 372-378. doi:10.1016/j.ijbiomac.2009.02.004Cazzaniga, A., Ballin, A., & Brandt, F. (2008). Hyaluronic acid gel fillers in the management of facial aging. Clinical Interventions in Aging, Volume 3, 153-159. doi:10.2147/cia.s2135Sun, S.-F., Chou, Y.-J., Hsu, C.-W., & Chen, W.-L. (2009). Hyaluronic acid as a treatment for ankle osteoarthritis. Current Reviews in Musculoskeletal Medicine, 2(2), 78-82. doi:10.1007/s12178-009-9048-5Yucel, T., Lovett, M. L., & Kaplan, D. L. (2014). Silk-based biomaterials for sustained drug delivery. Journal of Controlled Release, 190, 381-397. doi:10.1016/j.jconrel.2014.05.059Bettinger, C. J., Cyr, K. M., Matsumoto, A., Langer, R., Borenstein, J. T., & Kaplan, D. L. (2007). Silk Fibroin Microfluidic Devices. Advanced Materials, 19(19), 2847-2850. doi:10.1002/adma.200602487Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., … Cardona, A. (2012). Fiji: an open-source platform for biological-image analysis. Nature Methods, 9(7), 676-682. doi:10.1038/nmeth.2019Taddei, P., Pavoni, E., & Tsukada, M. (2016). Stability toward alkaline hydrolysis ofB.morisilk fibroin grafted with methacrylamide. Journal of Raman Spectroscopy, 47(6), 731-739. doi:10.1002/jrs.4892Perea, G. B., Solanas, C., Marí-Buyé, N., Madurga, R., Agulló-Rueda, F., Muinelo, A., … Pérez-Rigueiro, J. (2016). The apparent variability of silkworm ( Bombyx mori ) silk and its relationship with degumming. European Polymer Journal, 78, 129-140. doi:10.1016/j.eurpolymj.2016.03.012Hu, M., Sabelman, E. E., Tsai, C., Tan, J., & Hentz, V. R. (2000). Improvement of Schwann Cell Attachment and Proliferation on Modified Hyaluronic Acid Strands by Polylysine. Tissue Engineering, 6(6), 585-593. doi:10.1089/10763270050199532Monteiro, G. A., Fernandes, A. V., Sundararaghavan, H. G., & Shreiber, D. I. (2011). Positively and Negatively Modulating Cell Adhesion to Type I Collagen Via Peptide Grafting. Tissue Engineering Part A, 17(13-14), 1663-1673. doi:10.1089/ten.tea.2008.0346Ude, A. U., Eshkoor, R. A., Zulkifili, R., Ariffin, A. K., Dzuraidah, A. W., & Azhari, C. H. (2014). Bombyx mori silk fibre and its composite: A review of contemporary developments. Materials & Design, 57, 298-305. doi:10.1016/j.matdes.2013.12.052Atkins, E. D. T., Phelps, C. F., & Sheehan, J. K. (1972). The conformation of the mucopolysaccharides. Hyaluronates. Biochemical Journal, 128(5), 1255-1263. doi:10.1042/bj128125

Emergence of supercontraction in regenerated silkworm (Bombyx mori) silk fibers

The conditions required for the emergence of supercontraction in regenerated silkworm (Bombyx mori) silk fibers are assessed through an experimental approach that combines the spinning of regenerated fibers with controlled properties and their characterization by 13C solid-state nuclear magnetic resonance (NMR). Both supercontracting and non-supercontracting regenerated fibers are produced using the straining flow spinning (SFS) technique from 13C labeled cocoons. The short-range microstructure of the fibers is assessed through 13C CP/MAS in air and 13C DD/MAS in water, and the main microstructural features are identified and quantified. The mechanical properties of the regenerated fibers and their microstructures are compared with those of natural silkworm silk. The combined analysis highlights two possible key elements as responsible for the emergence of supercontraction: (1) the existence of an upper and a lower limit of the amorphous phase compatible with supercontraction, and (2) the existence of two ordered phases, β-sheet A and B, which correspond to different packing arrangements of the protein chains.Ministerio de Economía y Competitividad MAT2016-75544- C2-1-RMinisterio de Economía y Competitividad MAT2016-79832-RMinisterio de Economía y Competitividad DPI2016-78887-C3-1-RConsejería de Educación Comunidad de Madrid NEUROCENTRO-B2017/BMD-3760Ministerio de Educación, Ciencia y Cultura JP26248050Ministerio de Economía y Competitividad DPI2016-78887-C3-1-

Unexpected high toughness of Samia cynthia ricini silk gut

Silk gut fibers were produced from the silkworm Samia cynthia ricini silk glands by the usual procedure of immersion in a mildly acidic solution and subsequent stretching. The morphology of the silk guts was assessed by scanning electron microscopy, and their microstructure was assessed by infrared spectroscopy and X-ray diffraction. It was found that both naturally spun and Samia silk guts share a common semicrystalline microstructure. The mechanical characterization of the silk guts revealed that these fibers show an elastomeric behavior when tested in water, and exhibit a genuine ground state to which the fiber may revert independently of its previous loading history. In spite of its large cross-sectional area compared with naturally spun silk fibers, Samia silk guts show values of work to fracture up to 160 MJ m, much larger than those of most of their natural counterparts, and establish a new record value for this parameter in silk guts

Production of regenerated silkworm silk fibers from aqueous dopes through straining flow spinning

The possibility of spinning regenerated silkworm (Bombyx mori) fibers from a range of aqueous dopes by using a biomimetic approach based on straining flow spinning is explored in this work. It is found that spinning conditions can be established that allow fibers to be produced from environmentally friendly dopes with fibroin concentrations even one order of magnitude lower than that of the natural system. However, it is also found that the spinning process is favored and that the mechanical properties of the fibers are improved when dopes with higher fibroin concentration are employed. Since highly concentrated fibroin solutions in water are unstable, a stabilizing agent is required in order to obtain a spinnable dope at such large protein concentrations. CaCl2 is found to be an adequate stabilizing agent compatible with the straining flow spinning process. The optimization of the spinning parameters leads to the production of high-performance fibers with a work to fracture comparable to that of the natural material.Ministerio de Economía y Competitividad en España MAT2016-75544-C2- 1-R, MAT2016-79832-R y DPI2016-78887-C3-1-

Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

Background: In early 2020, COVID-19 massively hit Italy, earlier and harder than any other European country. This caused a series of strict containment measures, aimed at blocking the spread of the pandemic. Healthcare delivery was also affected when resources were diverted towards care of COVID-19 patients, including intensive care wards. Aim of the study: The aim is assessing the impact of COVID-19 on cardiac imaging in Italy, compare to the Rest of Europe (RoE) and the World (RoW). Methods: A global survey was conducted in May–June 2020 worldwide, through a questionnaire distributed online. The survey covered three periods: March and April 2020, and March 2019. Data from 52 Italian centres, a subset of the 909 participating centres from 108 countries, were analyzed. Results: In Italy, volumes decreased by 67% in March 2020, compared to March 2019, as opposed to a significantly lower decrease (p < 0.001) in RoE and RoW (41% and 40%, respectively). A further decrease from March 2020 to April 2020 summed up to 76% for the North, 77% for the Centre and 86% for the South. When compared to the RoE and RoW, this further decrease from March 2020 to April 2020 in Italy was significantly less (p = 0.005), most likely reflecting the earlier effects of the containment measures in Italy, taken earlier than anywhere else in the West. Conclusions: The COVID-19 pandemic massively hit Italy and caused a disruption of healthcare services, including cardiac imaging studies. This raises concern about the medium- and long-term consequences for the high number of patients who were denied timely diagnoses and the subsequent lifesaving therapies and procedures

Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

Objectives: The INCAPS COVID Oceania study aimed to assess the impact caused by the COVID-19 pandemic on cardiac procedure volume provided in the Oceania region. Methods: A retrospective survey was performed comparing procedure volumes within March 2019 (pre-COVID-19) with April 2020 (during first wave of COVID-19 pandemic). Sixty-three (63) health care facilities within Oceania that perform cardiac diagnostic procedures were surveyed, including a mixture of metropolitan and regional, hospital and outpatient, public and private sites, and 846 facilities outside of Oceania. The percentage change in procedure volume was measured between March 2019 and April 2020, compared by test type and by facility. Results: In Oceania, the total cardiac diagnostic procedure volume was reduced by 52.2% from March 2019 to April 2020, compared to a reduction of 75.9% seen in the rest of the world (p<0.001). Within Oceania sites, this reduction varied significantly between procedure types, but not between types of health care facility. All procedure types (other than stress cardiac magnetic resonance [CMR] and positron emission tomography [PET]) saw significant reductions in volume over this time period (p<0.001). In Oceania, transthoracic echocardiography (TTE) decreased by 51.6%, transoesophageal echocardiography (TOE) by 74.0%, and stress tests by 65% overall, which was more pronounced for stress electrocardiograph (ECG) (81.8%) and stress echocardiography (76.7%) compared to stress single-photon emission computerised tomography (SPECT) (44.3%). Invasive coronary angiography decreased by 36.7% in Oceania. Conclusion: A significant reduction in cardiac diagnostic procedure volume was seen across all facility types in Oceania and was likely a function of recommendations from cardiac societies and directives from government to minimise spread of COVID-19 amongst patients and staff. Longer term evaluation is important to assess for negative patient outcomes which may relate to deferral of usual models of care within cardiology